Evidence map›Paper›PMID 33524390›Full record

ArticleThe Journal of biological chemistry

Rab11-mediated post-Golgi transport of the sialyltransferase ST3GAL4 suggests a new mechanism for regulating glycosylation.

Masato Kitano, Yasuhiko Kizuka, Tomoaki Sobajima, Miyako Nakano, Kazuki Nakajima, Ryo Misaki, Saki Itoyama, Yoichiro Harada, Akihiro Harada, Eiji Miyoshi and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Endothelial cells sialylate IgG within the FcRn-mediated recycling pathway.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cells · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Masato KitanoDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan; Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yasuhiko KizukaDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan; Center for Highly Advanced Integration of Nano and Life Sciences (G-CHAIN), Gifu University, Gifu, Japan; Institute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.
Tomoaki SobajimaDepartment of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan.
Miyako NakanoGraduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Kazuki NakajimaFujita Health University, Aichi, Japan.
Ryo MisakiInternational Center for Biotechnology, Osaka University, Osaka, Japan.
Saki ItoyamaDepartment of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yoichiro HaradaDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan.
Akihiro HaradaDepartment of Cell Biology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Eiji MiyoshiDepartment of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan. Electronic address: emiyoshi@sahs.med.osaka-u.ac.jp.
Naoyuki TaniguchiDepartment of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Otemae, Chuo-ku, Osaka, Japan. Electronic address: glycotani@mc.pref.osaka.jp.
The University of Osaka · JPOsaka International Cancer Institute · JPOsaka International Cancer Institute · JPFujita Health University · JPHiroshima University · JPOsaka City University · JPOsaka International University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation, the most common posttranslational modification of proteins, is a stepwise process that relies on tight regulation of subcellular glycosyltransferase location to control the addition of each monosaccharide. Glycosyltransferases primarily reside and function in the endoplasmic reticulum (ER) and the Golgi apparatus; whether and how they traffic beyond the Golgi, how this trafficking is controlled, and how it impacts glycosylation remain unclear. Our previous work identified a connection between N-glycosylation and Rab11, a key player in the post-Golgi transport that connects recycling endosomes and other compartments. To learn more about the specific role of Rab11, we knocked down Rab11 in HeLa cells. Our findings indicate that Rab11 knockdown results in a dramatic enhancement in the sialylation of N-glycans. Structural analyses of glycans using lectins and LC-MS revealed that α2,3-sialylation is selectively enhanced, suggesting that an α2,3-sialyltransferase that catalyzes the sialyation of glycoproteins is activated or upregulated as the result of Rab11 knockdown. ST3GAL4 is the major α2,3-sialyltransferase that acts on N-glycans; we demonstrated that the localization of ST3GAL4, but not the levels of its mRNA, protein, or donor substrate, was altered by Rab11 depletion. In knockdown cells, ST3GAL4 is densely distributed in the trans-Golgi network, compared with the wider distribution in the Golgi and in other peripheral puncta in control cells, whereas the α2,6-sialyltransferase ST6GAL1 is predominantly localized to the Golgi regardless of Rab11 knockdown. This indicates that Rab11 may negatively regulate α2,3-sialylation by transporting ST3GAL4 to post-Golgi compartments (PGCs), which is a novel mechanism of glycosyltransferase regulation.

Indexed as

Animalsbeta-Galactoside alpha-2,3-SialyltransferaseGlycosylationGolgi ApparatusHeLa CellsHumansProtein Transportrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsRatsSialyltransferasestrans-Golgi Networkbeta-Galactoside alpha-2,3-Sialyltransferaserab11 GTP-Binding Proteinsrab GTP-Binding ProteinsSialyltransferasesST3GAL4 protein, humanglycanglycosylationglycosyltransferasemembrane trafficN-linked glycosylationposttranslational modificationRab11sialyltransferaseST3GAL4α2,3-sialylation

Identifiers

PMID33524390
PMCPMC7949161
OpenAlexW3127744119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.